Hypoxium has been acquired by Horizon Discovery, and will now be trading as Horizon Discovery Services, a wholly-owned subsidiary of Horizon Discovery.
Please view the Press Release or visit the Horizon Discovery website for more information.
Company
Why Horizon Discovery Services
With our core focus in oncology, we have experience in a wide range of drug targets and can provide guidance and background knowledge necessary to contribute to your discovery programs. This offering is strengthened by:
- Experienced scientists who approach the studies not only with academic rigor, but with the drug discovery process in mind
- Direct and transparent communication with the scientific team working on your project
- High quality and reproducible data delivered in a time-efficient manner
- Flexibility to fit your needs
With increasing pressure to deliver new chemical entities into the clinic in a cost efficient manner outsourcing is increasingly common in many areas of drug discovery. Outsourcing helps companies advance more drug candidates into their pre-clinical pipeline, move these compounds through the process faster and control development costs. This approach helps the development of a greater number of compounds without added capital expense, while allowing internal R&D assets to focus on core activities.
At Horizon Discovery Services, we recognise that in order for an outsourced approach to work successfully, a transparent and open relationship must be established that understands the needs and goals of the client company. Using our experience in scientific outsourcing we will ensure that your project will has the expertise, resources and management to successfully meet your needs.
